Because Ad-REIC has both direct and indirect effects on cancer therapy, it may become a powerful therapeutic option as a “one-bullet, two-arms” anti-cancer agent especially for NSCLCs, which often metastasize to other organs. The gene discussed is DKK3; the disease is cancer.